Associated Banc-Corp’s Atara Biotherapeutics ATRA Stock Holding History

Associated Banc-Corp’s Portfolio ATRA Stock Details ATRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-3	Closed	-$1K	–	333
2020 Q4	$1K	Hold	3	–	–	﹤0.01%	894
2020 Q3	$1K	Buy	+3	New	+$1.02K	﹤0.01%	825

Other funds holding ATRA

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Associated Banc-Corp's ATRA Position: Q1 2021 in Review

Associated Banc-Corp sold out of Atara Biotherapeutics (ATRA) in Q1 2021, closing a stake of 3 shares — an estimated $1K sold.

Associated Banc-Corp first reported a position in ATRA in Q3 2020 and held it in 2 quarters. The position peaked at $1K in Q4 2020. 151 funds tracked by Wall St. Rank hold ATRA as of Q1 2021.

Associated Banc-Corp reported no remaining Atara Biotherapeutics position as of Q1 2021 after selling out during the quarter.
Associated Banc-Corp sold 3 Atara Biotherapeutics shares in Q1 2021, an estimated $1K.
Associated Banc-Corp first reported a position in Atara Biotherapeutics in Q3 2020 and held it in 2 quarters.
Associated Banc-Corp's Atara Biotherapeutics position peaked at $1K in Q4 2020.
151 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q1 2021.

Based on Associated Banc-Corp's 13F filing for Q1 2021, filed 5 May 2021.